Proteomics Market worth $72.9 billion | MarketsandMarkets
Comunicato Precedente
Comunicato Successivo
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731
Browse in-depth TOC on "Proteomics Market"
707 - Tables
49 - Figures
604 - Pages
Proteomics Market Scope:
Spectroscopy accounted for the largest share of the instrumentation technologies segment in the proteomics market in 2022.
Based on instrumentation technologies, the proteomics market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. In 2022, spectroscopy accounted for the largest share of the proteomics market for instrumentation technologies. This segment's large share can be attributed to factors such as being widely utilized for studying proteins, their structures, interactions, and functions. Spectroscopic techniques provide valuable insights into the properties of proteins, including their secondary and tertiary structures, conformational changes, and ligand binding.
Mass spectrometry technology accounted for the largest share of the type segment in the proteomics market in 2022.
Based on type, spectroscopy instrumentation technology is categorized into three sub-segments— mass spectrometry (MS), NMR spectroscopy, and circular dichroism (CD) spectroscopy. In 2022, mass spectrometry accounted for the largest share of the spectroscopy instrumentation technology segment. Factors such as the MS can analyze large numbers of samples in a short period of time, making it ideal for large-scale proteomics studies is attributed to its large share.
Gel electrophoresis technology accounted for the largest share of the type segment in the proteomics market in 2022.
Based on type, electrophoresis instrumentation technology is categorized into two sub-segments— Gel and capillary electrophoresis. In 2022, gel electrophoresis accounted for the largest share of the electrophoresis instrumentation technology segment. Factors such as the increasing demand for gel electrophoresis in proteomics research and personalized medicine is a major factor driving the growth of the overall gel electrophoresis market.
Asia Pacific is likely to grow at the highest growth rate during the forecast period.
Based on the region The global proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the proteomics market during the forecast period. The growth of the pharmaceuticals and life sciences market in the region is primarily driven by the rising prevalence of chronic disease conditions, the rising R&D expenditure, especially in the area of drug discovery & development, and significant investments in the development of therapeutics mAbs.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=731
Proteomics Market Dynamics:
Drivers:
Restraints:
Opportunities:
Challenges:
Key Market Players:
Some of the prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) and among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=731
Recent Developments:
Proteomics Market Advantages:
Overall, the proteomics market provides a range of advantages that contribute to advancements in medical research, diagnostics, and personalized medicine. It holds immense potential for improving disease understanding, patient care, and the development of targeted therapies in the future.
Proteomics market - Report Highlights:
Related Reports:
Electrophoresis Market - Global Forecasts to 2028
Bioinformatics Market - Global Forecasts to 2027
Liquid Handling System Market - Global Forecasts to 2027
Next Generation Sequencing Market - Global Forecasts to 2027
Molecular Diagnostics Market - Global Forecasts to 2027
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/proteomic-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/proteomics.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/proteomics-market-worth-72-9-billion--marketsandmarkets-301838536.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
